Breast Cancer
-
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
-
Musical Toxicity an Effect of Cancer TreatmentStudy finding cancer treatment affects ability to play or sing music highlights need for physical therapy, experts say.
by Kyle Bagenstose
-
Overcoming ResistancePeople with metastatic hormone receptor-positive breast cancer are living longer, thanks to new targeted therapies and endocrine therapies that can be prescribed when treatment resistance develops.
by Kendall K. Morgan
-
Q&A
A Journey of Self-discoveryKailee McGee’s short film explores how a breast cancer diagnosis reshaped how she sees herself.
by Tyler Santora
-
Treating HER2-ultralow Breast CancerFDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
-
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
-
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona
-
Understanding the Federal Rule on Breast Tissue Density ReportsScreening mammography reports will include breast density and an explanation in common language.
by Sandra Gordon
-
Forward Look
A More Targeted PARP InhibitorEarly research suggests treatment could have higher potency and less toxicity for people with BRCA-related cancers.
by Marci A. Landsmann
